Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

Monkey research attracts international attention

2016-07-11

Prof Trudy Turner from the University of
Wisconsin-Milwaukee and Prof Paul Grobler
from the Department of Genetics at the
University of the Free State, together with one
of the students researching monkey genes.
Photo: Siobhan Canavan

For this year’s Summer School programme, Prof Paul Grobler, from the University of the Free State Department of Genetics focuses on research about the conflict between monkeys and humans in areas where monkeys are regarded as problem animals.

Global expert part of research

This year, Prof Grobler is hosting a group of students and lecturers from the United States of America (USA). The group includes Prof Trudy Turner from the University of Wisconsin-Milwaukee (UWM), a global expert on vervet monkeys. She has been working with the Department of Genetics at the UFS for the past fifteen years, and has also been appointed as an Affiliated Professor in the department.

“The Summer School programme is an opportunity for the American Primatology students to gain practical experience in Africa,” says Prof Grobler.

International interest in Summer School

This year’s Summer School programme involves four lecturers and nine students. The lecturers are from the University of Wisconsin-Milwaukee (UWM), the University of California, Los Angeles (UCLA), Boston University, and Central Washington University.

“We use the genetic information to determine
how monkeys historically infiltrated the
different areas in South Africa.”

This year’s focus is on the genetic structure of the monkeys in South Africa, and research that is being done on the differences and similarities in monkeys from different areas. “We use the genetic information to determine how monkeys historically infiltrated the different areas in South Africa,” says Prof Grobler.

Local nature reserve acting as host

The group will perform field work, including observing monkeys in the Soetdoring Nature Reserve, as well as laboratory work in the department, where they will be assisted by two laboratory technicians.

Two years ago, Prof Grobler and his department tested this idea on a smaller scale, and now they hope to make this a regular event.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept